Reggae superstar Jah Cure has returned to the pole position of the Billboard Reggae album charts with his critically acclaimed album, ‘The Cure’.
The album’s return to the top of the Billboard chart comes 26 weeks after the album first made its debut at the top of the chart.
Released in July by VP Records, the album has garnered both critical and commercial acclaim. Initially, the album topped Billboard’s Reggae Album for three weeks before becoming a fixture in the top ten of the chart for the last 26 weeks. In December, it was reported that the album had sold just over 10,000 copies, according to sales monitor Soundscan.
Since the Grammy nomination was announced, The Cure has received a fillip in sales.
“I have been campaigning hard to raise awareness of the album, hopefully with voters in the Academy, but that campaigning has boosted sales. Right now, The Cure is approaching 15,000 copies,” a proud Jah Cure said.
deep discounting
Jah Cure’s return to the apex of the Billboard reggae charts, is indeed historic, but not unprecedented. In 2014, Bob Marley’s 1984 Legend album zoomed from No. 100 to No. 5 on the Billboard 200 chart in September of that year thanks to deep discounting at the Google Play store during the tracking week that ended September 7. Marley also held the number one position on the Billboard reggae charts, returning after a hiatus of almost two decades.
The retailer slashed the album’s price to 99 cents (down from normally around $9), helping spark its 41,000 sales for the week (up 1,166 percent).
“It is quite a feat for Jah Cure because this does not happen often with indigenous reggae acts. Our records show that Bob Marley, Snoop Dogg and bands from California have done it before, but it is still a phenomenal achievement ,” Neil Diamond, senior director of A &R at VP Records, said.
The 37-year-old singer got a Grammy nomination with The Cure, one of five nominees for Best Reggae Album at the 2016 Grammy Awards.
You must log in to post a comment.